Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-007415
Filing Date
2025-09-22
Accepted
2025-09-22 16:27:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4067
  Complete submission text file 0001950047-25-007415.txt   5728
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Subject) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37852 | Film No.: 251330424
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CALITHERA BIOSCIENCES 343 OYSTER POINT BLVD, SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address
Waddill William D. (Reporting) CIK: 0001553338 (see all company filings)

Type: 144